---
layout: post
title: "Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Engineered Influenza Neuraminidase Antigens"
date: 2026-02-05 18:58:58 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-09156
original_published: 2022-04-28 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Engineered Influenza Neuraminidase Antigens

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 28, 2022 00:00 UTC
**Document Number:** 2022-09156

## Summary

The National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of an exclusive, sublicensable patent license to the University of Washington, located in Seattle, State of Washington, U.S.A. in its rights to the inventions and the patent applications listed in the Supplementary Information section of this notice.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/28/2022-09156/prospective-grant-of-exclusive-license-inter-institutional-agreement-institution-lead-engineered)
- API: https://www.federalregister.gov/api/v1/documents/2022-09156

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
